In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 22.9% in the afternoon session after the ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported revenue ahead of Wall Street’s expectations in ...

This was the stock's second consecutive day of losses.

Q2 2025 Earnings Call Transcript July 24, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS ...

West Pharmaceutical stock was climbing 24% on Thursday, putting it on track for the strongest-ever single-day percentage ...

Discover West Pharma's robust Q2 2025 performance with 6.8% organic sales growth! Learn about raised guidance, high-margin gains, & GLP-1 market ...

Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.

This was the stock's third consecutive day of losses.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Let’s dig into the relative performance of West Pharmaceutical Services (NYSE:WST) and its peers as we unravel the ...

Key Points - Adjusted EPS was $1.84 in Q2 FY2025, beating the $1.51 estimate by 21.9%, and GAAP revenue exceeded expectations by $40.4 million. Proprietary Products sales rose 10.7%, driven by strong ...